News
The specter of Carnival 1952, with the much quoted “Rain Don’t Stop de Carnival,” was in repeat mode 73 years later on ...
10d
Sporting News on MSNLiverpool title parade and Premier League trophy presentation: Key details as Arne Slot's champions celebrateLiverpool wrapped up the Premier League title with a 5-1 win over Tottenham Hotspur. Unlike in 2020, there's going to be a ...
Liverpool will have a parade to celebrate their Premier League ... Trent Alexander-Arnold Tradition dictates that the trophy presentation will be held on the final weekend of the season.
Sign up and tell us which team you support to get personalised updates about your club. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of ...
Liverpool have confirmed the date for their open-top bus victory parade after they were crowned Premier League champions. The Reds have exceeded expectations in Arne Slot’s first season at Anfield and ...
today announced the presentation of a poster at the American Association for Cancer Research (AACR) Annual Meeting, taking place April 25-30, 2025 in Chicago. The presentation describes the ...
today announced the presentation of a poster at the American Association for Cancer Research (AACR) Annual Meeting, taking place April 25-30, 2025 in Chicago. The presentation describes the company’s ...
CONCORD, Mass.–(BUSINESS WIRE)–ClearB Therapeutics, Inc., a company developing therapeutic vaccines designed to drive a functional cure for Hepatitis B, announced today that an abstract will be ...
PORTVILLE — It was Tuesday afternoon, and Evelyn Sabina was reviewing another successful Dream It Do It event with Jeff Belt. During the conversation, ...
IBSRELA (tenapanor) is a locally acting inhibitor of the sodium/hydrogen exchanger 3 (NHE3), an antiporter expressed on the apical surface of the small intestine and colon primarily responsible ...
Two abstracts accepted for poster presentation highlight Company’s proprietary Conditionally Active Biologic (CAB) technology Differentiated preclinical activity for CAB anti-Nectin4-antibody drug ...
Two abstracts accepted for poster presentation highlight Company’s proprietary Conditionally Active Biologic (CAB) technology Differentiated preclinical activity for CAB anti-Nectin4-antibody ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results